➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Mallinckrodt
Johnson and Johnson
Colorcon
Dow

Last Updated: January 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Phosphoric acid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Phosphoric acid?

Phosphoric acid is an investigational drug.

There have been 7 clinical trials for Phosphoric acid. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.

The most common disease conditions in clinical trials are Gingival Recession, Dental Caries, and Syndrome. The leading clinical trial sponsors are CrystalGenomics, Inc., Fundação de Amparo à Pesquisa do Estado de São Paulo, and Cairo University.

There are three hundred and sixty US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Phosphoric acid
TitleSponsorPhase
Ropivacaine Plasma Concentration With or Without Epinephrine for Posterior Quadratus Lumborum BlockFondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.Fundação de Amparo à Pesquisa do Estado de São PauloN/A
Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.Universidade Estadual Paulista Júlio de Mesquita FilhoN/A

See all Phosphoric acid clinical trials

Clinical Trial Summary for Phosphoric acid

Top disease conditions for Phosphoric acid
Top clinical trial sponsors for Phosphoric acid

See all Phosphoric acid clinical trials

US Patents for Phosphoric acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phosphoric acid   Start Trial Colloidal sols of antimony pentoxide in an aqueous medium and their preparation Laurel Industries, Inc. (Cleveland, OH)   Start Trial
Phosphoric acid   Start Trial Unique bone regeneration tricalcium phosphate The United States of America as represented by the Secretary of the Army (Washington, DC)   Start Trial
Phosphoric acid   Start Trial Process for preparing ceftazidime pentahydrate Eli Lilly and Company (Indianapolis, IN)   Start Trial
Phosphoric acid   Start Trial Method for the preparation of 4-acetoxystyrene Hoechst Celanese Corporation (Somerville, NJ)   Start Trial
Phosphoric acid   Start Trial Alkynylamino-nucleotides E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phosphoric acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phosphoric acid Canada CA1099610 1995-08-18   Start Trial
Phosphoric acid Germany DE2637185 1995-08-18   Start Trial
Phosphoric acid France FR2321324 1995-08-18   Start Trial
Phosphoric acid United Kingdom GB1563214 1995-08-18   Start Trial
Phosphoric acid Italy IT1065149 1995-08-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Mallinckrodt
Johnson and Johnson
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.